Pathology Nucleus is a consultant led pathology group specialising in AI ready pathology datasets, central pathology review for clinical trials, and high quality diagnostic reporting for pharmaceutical, biotech, and CRO partners. Our team of consultant pathologists and biomedical scientists works at the interface of medicine, data, and technology to deliver clinically robust, regulator ready outputs for AI development and clinical research under full clinical governance.

Consultant governed datasets and workflows for scalable clinical AI development.
Annotation Frameworks
Design and validation of tumour boundaries, grading systems, and biomarker protocols to generate regulator ready AI training datasets.
Clinical QA Oversight
Consultant pathologist governance and sign off to ensure annotations are accurate, r
Consultant governed datasets and workflows for scalable clinical AI development.
Annotation Frameworks
Design and validation of tumour boundaries, grading systems, and biomarker protocols to generate regulator ready AI training datasets.
Clinical QA Oversight
Consultant pathologist governance and sign off to ensure annotations are accurate, reproducible, and clinically defensible for AI validation and regulatory submission.
Strategic CRO and Pharma Support
End to end annotation and dataset strategy for pharmaceutical, CRO, and biotech clients building hybrid human AI pathology pipelines.

Specialist consultant led pathology to support regulated clinical research.
Clinical Trial Pathology
Central pathology review of biopsies and trial specimens to support endpoint assessment and regulatory reporting.
Biomarker Analysis
Predictive and prognostic biomarker evaluation with study ready reporting for targeted therapy development.
AI
Specialist consultant led pathology to support regulated clinical research.
Clinical Trial Pathology
Central pathology review of biopsies and trial specimens to support endpoint assessment and regulatory reporting.
Biomarker Analysis
Predictive and prognostic biomarker evaluation with study ready reporting for targeted therapy development.
AI Ready Research Datasets
Generation of high quality research datasets compatible with AI model development and translational research pipelines.

Consultant issued pathology reporting to support hospitals, clinicians, and research sponsors.
Histopathology
Comprehensive tissue analysis with consultant issued diagnostic reports for hospitals, private healthcare providers, and CROs.
Haematology
Specialist review of blood and bone marrow specimens with integrated reporting for leukaemia, a
Consultant issued pathology reporting to support hospitals, clinicians, and research sponsors.
Histopathology
Comprehensive tissue analysis with consultant issued diagnostic reports for hospitals, private healthcare providers, and CROs.
Haematology
Specialist review of blood and bone marrow specimens with integrated reporting for leukaemia, anaemia, and other haematological disorders.
Molecular and Cytogenetics
DNA and RNA based diagnostics including mutation analysis with clinically actionable reporting for personalised medicine.
Second Opinions
Independent consultant reports to confirm or refine diagnoses for clinicians, patients, and research sponsors.
Consultant pathologists with GMC and ABPath certification delivering regulator ready pathology for AI and clinical trials.








Pathology Nucleus